ADHD and endocrine disorders, including Polycystic Ovary Syndrome (PCOS) and thyroid conditions, are increasingly recognized for their overlapping symptoms and shared hormonal pathways. Both ADHD and PCOS involve complex interactions between brain chemistry and hormone regulation, affecting neurotransmitters like dopamine and fluctuations in estrogen levels which influence cognitive functions including attention and executive processing. Women diagnosed with both ADHD and PCOS often experience heightened challenges such as irregular menstrual cycles, mood swings, energy crashes, and insulin resistance, which can exacerbate ADHD symptoms. The cyclical nature of hormone fluctuations can lead to worsened executive dysfunction during certain phases of the menstrual cycle, making symptom management more complex. It's important to understand that these symptoms are not simply "all in your head"; rather, they reflect a dynamic conversation between hormonal imbalances and brain function. For clinicians and healthcare providers, recognizing the overlap between ADHD and endocrine disorders is essential for offering targeted, individualized treatment approaches that address both neurological and hormonal aspects. Recent research highlights the significant role of estrogen in modulating neurotransmitters critical for focus and attention, explaining why symptoms can vary with hormonal changes. Additionally, insulin resistance linked to PCOS can affect metabolic health and energy levels, further impacting cognitive performance and daily functioning. Women navigating these dual diagnoses benefit from multidisciplinary care that integrates endocrinology and neurodevelopmental expertise. Support strategies such as symptom tracking aligned with hormonal cycles, lifestyle modifications to improve insulin sensitivity, and tailored ADHD management plans can substantially improve quality of life. Awareness campaigns, like #PCOSAwareness and #ADHDandHormones, play an important role in educating patients and providers about this intersection. Expanding research in this area will enhance understanding and treatment options, empowering women to better manage their health and cognitive symptoms in tandem.